Sign in
4

Changes in Ownership

Vera Therapeutics, Inc. Filed Acc 0001209191-22-052719

President and CEO sold 32,000 shares at an average $20.90 ($668,773)

  • President and CEO acquired 32,000 shares (option exercise)

From the SEC's structured data for this filing

Trades in this filing

Fordyce Marshall · President and CEO

Table I: Non-derivative

10 lines
Date Transaction Shares Price Value Owned after D/I
2022-10-03 Exercise or conversion : show line 1 in the form +11,369 $2.90 $32,934 192,519 D
2022-10-03 Sale : show line 2 in the form −11,369 $20.39 $231,757 181,150 D
2022-10-03 Exercise or conversion : show line 3 in the form +2,408 $2.90 $6,975 183,558 D
2022-10-03 Sale : show line 4 in the form −2,408 $21.16 $50,951 181,150 D
2022-10-04 Exercise or conversion : show line 5 in the form +6,899 $2.90 $19,985 188,049 D
2022-10-04 Sale : show line 6 in the form −6,899 $20.29 $139,971 181,150 D
2022-10-04 Exercise or conversion : show line 7 in the form +10,418 $2.90 $30,179 191,568 D
2022-10-04 Sale : show line 8 in the form −10,418 $21.69 $225,994 181,150 D
2022-10-04 Exercise or conversion : show line 9 in the form +906 $2.90 $2,625 182,056 D
2022-10-04 Sale : show line 10 in the form −906 $22.19 $20,101 181,150 D
Open-market sales · 32,000 sh · avg $20.90 · $668,773

Table II: Derivative

2 lines
Date Transaction Shares Owned after D/I
2022-10-03 Exercise or conversion : show line 11 in the form Stock Option (Right to Buy) −13,777 965,435 D
2022-10-04 Exercise or conversion : show line 12 in the form Stock Option (Right to Buy) −18,223 947,212 D
Loading xslF345X03/doc4.xml…